Sdi Share Discussion Threads

[pj 1] 25/8/2017 08:16

It's not often you see reasonably sized Directors Buys in a small growth Company have nil effect

[buywell3] 25/8/2017 08:08

Always nice to see the BOD buying their own paper

[rivaldo] 24/8/2017 12:24

Meaningful director buying just reported - that should get things going nicely:



"Scientific Digital Imaging (AIM: SDI, "SDI" or the "Company") was notified on 24 August 2017 that, on the same day, Ken Ford, Chairman of the Company, purchased 100,000 ordinary shares of 1p each in the Company at 26.45p per share. The Company was also notified that, on the same day, David Tilston, Non-Executive Director of the Company, purchased 25,000 ordinary shares of 1p each in the Company at 26.45p per share."

[pj 1] 24/8/2017 10:17

Under the radar and a quiet BB is fine with me.

[buywell3] 24/8/2017 09:58

finncap are light again IMO at 32p ... same as they were at 19p
'Behind the curve' is the phrase that comes to mind


Lack of reaction today tells me that the PR company SDI employ do not seem to be getting the message across


'Off the market radar' ... is another phrase therefore to be added

The lack of different posters here also adds to the above

I hope to see more come in due course

















when I have finished adding

[rivaldo] 24/8/2017 09:50

That's good to hear Hastings. OT : please do mention FDEV - I think I love them :o)) And KWS. And IQE. And of course SDI :o))

[hastings] 24/8/2017 09:22

I think they have others in the frame riv. Oh, can I mention FDEV;

[rivaldo] 24/8/2017 09:20

Cheers hastings. I note that as well as increasing the target price to 32p, Finncap have raised forecasts to 1.9p EPS this year and 2.2p EPS next year.

A forward P/E of 12 seems pretty good value to me.

Hopefully SDI still have the firepower for another acquisition of a similar size this year from current resources and financed similarly to today's purchase.

[buywell3] 24/8/2017 08:00

It looks to me like Mike Creedon has bought a company that most likely ATIK have been acquiring cooling products from for their cameras and most likely designing new cooling products for new ATIK cameras ... one of which should come to market within the next 6 to 8 weeks.


So if that is the case , margins for SDI look set to go higher


Plus the technical know-How re the University ties could lead to enhanced design improvements in future new cameras AND visa versa ATC can learn from ATIK about what the camera sales development requirements coming down the track are going to be and improve their offerings further and in a timely fashion.

The issue of SDI shares at 26p ... as part of the acquisition plus use of some debt whist bank rates remain for the time being low ... I also applaud.

The discounting of shares for acquisitions upset quite a lot of shareholders so this now sets the bar at a much higher level.

If things now proceed swimmingly well ... then the next issue of shares for the next acquisition should be at a premium to the prevailing share price at the time.


Shareholders will then be ecstatic

[hastings] 24/8/2017 07:51

FinCap issued a fairly brief update target price raised to 32p.This looks a very good buy and there is certainly scope for scaling up via the existing businesses/routes.

[buywell3] 24/8/2017 07:37

The CEO and BOD of SDI certainly have the gift when it comes to buying other small cap companies.

It is a strategy that is now paying off handsomely as turnover and profits get set to grow further in the current year with a full 12 months from Astles instead of the 4 months in the last numbers ... then in the following year from this acquisition and new products which will be launched over the next 12 months

Plus of course ProReveal sales into the NHS and then US

Happy days .... and the current FinnCap target of 30p should now get hit within days if not today

I have now raised my call for 2018 to 43p

dyor


24 August 2017

Scientific Digital Imaging plc
("SDI", the "Company" or the "Group")
(AIM: SDI)

Acquisition of Applied Thermal Control Limited and Issue of Equity

The Board of Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, is pleased to announce the acquisition of Applied Thermal Control Limited ("ATC") for an initial consideration of £686,000, with the total consideration (including earn-out) capped at £1.2 million, plus an additional cash payment for net assets at completion (the "Acquisition").

Highlights:

· ATC designs and manufactures precision re-circulating chillers, coolers and heat exchangers used to control the thermal environment within a wide variety of applications including within the scientific instrument support market (including electron microscopes, X-ray, diffraction and mass spectrometers).

· For the year ended 31 December 2015, ATC achieved revenue of £1.12 million, gross profit of £689,000 and profit before tax of £196,000. For the year ended 31 December 2016, ATC achieved revenue of £1.20 million, gross profit of £755,000 and profit before tax of £129,000, the lower profit before tax in 2016 reflecting the cost of investment for growth in sales and marketing.

· The Acquisition is in line with the Group's strategy of acquiring complementary businesses and the Board has identified areas within ATC with potential for growth.


Ken Ford, Chairman of SDI said:
"ATC represents another exciting step in our Group growth strategy. ATC is a complementary fit to the Group and provides potential areas for growth alongside a talented workforce. The acquisition is in line with our previously announced acquisition strategy and is expected to be earnings enhancing in its first full year of ownership."


About Applied Thermal Control Limited

ATC designs and manufactures precision re-circulating chillers, coolers and heat exchangers used to control the thermal environment within a wide variety of applications. ATC products are used within the scientific instrument support market (including electron microscopes, X-ray, diffraction and mass spectrometers) where cooling is required to either prevent damage to components, reduce distortion in processes, improve repeatability and stability in analysis or remove heat from chemical reactions.

ATC was founded in 1995 and has close ties with Loughborough University and is based in Whitwick, Leicestershire and employs 13 staff.

For the year ended 31 December 2015, ATC achieved revenue of £1.12 million, gross profit of £689,000 and profit before tax of £196,000. For the year ended 31 December 2016, ATC achieved revenue of £1.20 million, gross profit of £755,000 and profit before tax of £129,000, the lower profit before tax in 2016 reflecting the cost of investment for growth in sales and marketing. Approximately 60 per cent. of ATC's sales are to OEMs with remaining sales being to end-users (predominantly Universities). 30 per cent. of sales are exported, mainly to the USA. Sales include consumable products such as heat exchanger fluids providing a recurring revenue stream.


Acquisition rationale

The Acquisition is in line with the Group's strategy of acquiring complementary businesses and the Board has identified areas within ATC with potential for growth.

ATC has a talented workforce and CEO, Robert Poniatowski, will remain in place on completion of the Acquisition.

Consideration for the Acquisition

Total consideration (excluding an additional cash payment for net assets at completion) is capped at £1.2 million. This is made up of £486,000 in cash, plus new Ordinary Shares equating to £200,000 at completion, followed by deferred consideration of 4x earnings before interest and taxation less the £686,000 paid at completion on finalisation of ATC's audited accounts for the year ended 31 December 2017.

SDI has funded the initial cash consideration from existing cash resources together with a £450,000 loan from NatWest Bank repayable over five years at an interest rate of 4.5% per annum over Natwest base rate.

The £200,000 of new Ordinary Shares issued at completion is represented by 769,230 Ordinary Shares issued at 26 pence per share, being the average mid closing price for the five business days prior to the date of this announcement.

Issue of new Ordinary Shares in SDI

As referred to above, as part of the consideration for the Acquisition, SDI has issued 769,230 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares").

Application will be made to the London Stock Exchange for the 769,230 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 1 September 2017.

After Admission, the total number of Ordinary Shares in issue will be 89,609,424 and the total number of voting rights will therefore be 89,609,424. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

[rivaldo] 24/8/2017 07:24

Indeed - nicely earnings-enhancing, and looks like a cheap price too given £1.2m maximum consideration for a likely £200,000 PBT given lower sales and marketing investment costs after 2016:



The recurring income and overseas sales are also encouraging, and I'm assuming there's potential for integration/sales synergies with SDI's existing product portfolio as a "complementary businesses" with "areas within ATC with potential for growth".

[hastings] 24/8/2017 07:03

So, very much as expected, another smaller fit announced which the company expects to be able to grow and will immediately be earning enhancing.
I'm going to be catching up with the company before he end of the week so will add some comment.

[cockerhoop] 21/8/2017 12:06

Good stuff Hastings! PJ1 hope to see you in Manchester - I've penciled it in.

[hastings] 21/8/2017 10:38

Stumbled on this piece from the Plymouth NHS Trusts Annual Report released a few months back.

There continues to be progress towards compliance with IPG 196 (Patient
safety and reduction of risk of transmission of Creutzfeldt-Jakob disease
(CJD) via interventional procedures), which is monitored and reviewed
through a compliance action plan. The SDU has acquired a Pro Reveal protein
detection system which can identify levels of proteins including prion related
proteins on washed surgical instruments.
Whilst enabling local efficacy of washer disinfectors (and associated trend
analysis) to be determined ,it is hoped that the system will be used for research
purposes, including a study to establish the rate of prion removal from surgical
Instruments that have been used in High Risk Procedures (as determined by
IPG196) after successive washes in compliant washer Disinfectors.

[pj 1] 17/8/2017 17:53

All being well I will be there.

[hastings] 17/8/2017 17:46

I see SDI presenting at Manchester sharesoc in October. Bit far for me may be of interest to others though.

[hastings] 15/8/2017 14:29

I would think the news on Japanese Fungus in UK hospitals can only strengthen the case for ProReveal

[buywell3] 12/8/2017 15:38

This is a very quiet BB ... I had hoped my arrival might have bought in a few new faces , still there is still time for things to improve.

I hope to see it kick into life with the advent of the next acquisition , which should be from cash and from existing facilities , so no shares placed this time.

I am expecting the SDI BOD will have once again picked a gem of a fit for the company

Cross selling opportunities, enhanced margins and earnings enhancing from day one.

Not asking much am I ... but that is what they have been doing ... so why change now ?


The other big news which I expect to see within the next 2 months is for the DoH to announce the bulk purchase of around 40 to 50 ProReveal machines to supplement the 10 recently acquired by the NHS over the last couple of months , and satisfy the D0H requirement that all 50 NHS SSD's involved in neurological and eye surgery , have ProReveal put into place and in use before xmas this year.

IMO two nice outcomes to look forwards to.

dyor

[buywell3] 10/8/2017 16:18

For newbes

Synoptics is part of SDI




[phone] [e-mail]
Latest News

Wednesday 2nd August, 2017

HTM01:01

We are pleased to announce that the ProReveal has been adopted to date by 10 NHS Trusts in the UK to comply with the protein detection requirements of the updated HTM01:01. The ProReveal is not only helping with their compliance - it is also giving them technology, that is helping with their wash process optimisation.

[buywell3] 06/8/2017 16:34

Macaque study heightens concerns about human susceptibility to CWD

June 28, 2017

''Macaque monkeys contracted chronic wasting disease after eating meat from CWD-positive deer, according to Canadian researchers.

The findings are the first known oral transmissions of the prion disease to a primate and have heightened concerns of human susceptibility to CWD.

“The assumption was for the longest time that chronic wasting disease was not a threat to human health,” said Stefanie Czub, prion researcher with the Canadian Food Inspection Agency, in remarks published June 24 in The Tyee, a Vancouver, B.C. magazine. "But with the new data it seems we need to revisit this view to some degree."

Monkeys are used in research only when it is not possible to use other species. They are employed primarily in studies into the disorders, structure and function of the brain.

Monkeys can only be used in research when no alternative – animal or non-animal – is suitable. But they are still vital to our understanding of complex human diseases such as Alzheimer’s and Parkinson’s

''Three of five macaques that were fed infected white-tailed deer meat over a three-year period tested positive for CWD.The meat fed to the macaques represented the human equivalent of eating a seven-ounce steak per month.''





According to a Scientific American article, misdiagnoses of prion-involved disease in humans may be more widespread than previously believed:

In the human form of mad cow disease, called Creutzfeldt-Jakob, a person’s brain deteriorates — literally developing holes that cause rapidly progressing dementia. The condition is fatal within one year in 90 percent of cases. The culprits behind the disease are prions — misfolded proteins that can induce normal proteins around them to also misfold and accumulate. Scientists have known that these self-propagating, pathological proteins cause some rare brain disorders, such as kuru in Papua New Guinea. But growing evidence suggests that prions are at play in many, if not all, neurodegenerative disorders, including Alzheimer’s, Huntington’s and Parkinson’s, also marked by aggregations of malformed proteins.

[pj 1] 05/8/2017 21:52

buywell3
Out of interest, did you previously post as 'buywell1' and 'buywell2'?

[buywell3] 05/8/2017 17:02

The USA ProReveal Distributor needs to be updated:-



...... Evidence for Person-to-Person Transmission of Alzheimer's Pathology ......

Study raises question about whether proteins implicated in the disease are capable of spreading through medical procedures.

hTT ps://www.scientificamerican.com/article/evidence-for-person-to-person-transmission-of-alzheimer-s-pathology/